Printer Friendly

Browse Pharmaceutical industry topic

Product development subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
New trial for UK vaccine after glitch raises fears. MARTIN BAGOT Health Editor Nov 27, 2020 206
Vaccine trial with best results wasn't tested on over-55s; Daily RECORD MORE AT DAILYRECORD.CO.UK UK jab delay looms over testing error. MARTIN BAGOT Nov 27, 2020 496
BioNTech and Fosun commence Phase II trial of BioNTech's COVID-19 vaccine in China. Nov 25, 2020 152
BioNTech and Fosun commence Phase II trial of BioNTech's COVID-19 vaccine in China. Nov 25, 2020 156
UK vaccine gives hope as US eyes mass rollout. Nov 25, 2020 1446
Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial and easing of lockdown restrictions. Nov 24, 2020 340
Metro Manila, Davao, Cebu top priority in vaccine distribution - Galvez. Nov 24, 2020 678
Covid-19 vaccines offer hope as world leaders plan for future. Nov 24, 2020 772
US approves Regeneron antibody treatment given to Trump. Nov 23, 2020 577
G20 pushes for global vaccine access. Nov 23, 2020 997
GlaxoSmithKline Starts Phase 3 Trial Of RSV Maternal Candidate Vaccine. Nov 23, 2020 202
Oxford Covid vaccine could be approved within a week with NHS told prepare for December 1; Following the results from the University of Oxford vaccine trial, the NHS has been told to prepare to start giving out the jabs on December 1. By, Martin Bagot & Shivali Best Nov 23, 2020 648
Trials for antibody treatment set to begin in the UK. Nov 21, 2020 347
Trials for AstraZeneca's coronavirus 'antibody cocktail' start in the UK; The treatment, aimed at people with a weakened immune system who cannot be vaccinated could prevent Covid-19 infection for up to 12 months. The clinical trial programme will recruit 5,000 participants. By, Chiara Fiorillo Nov 21, 2020 939
Trials For AstraZeneca's Covid-19 Treatment Set To Begin In UK. Nov 21, 2020 682
AstraZeneca open to conduct COVID-19 vaccine clinical trials in PH. Nov 20, 2020 282
AstraZeneca COVID-19 vaccine shows encouraging phase II results in peer-reviewed study. Clinical report Nov 20, 2020 324
UK pharma seeks to conduct vaccine trials in Philippines. Nov 20, 2020 1044
British drug maker interested in holding clinical trials here. Nov 20, 2020 594
Covid 19 vaccines: how do the Oxford AstraZeneca, Pfizer and Moderna jabs compare, are there side effects, and how effective is each? Three coronavirus jabs are in late trial stages raising hopes of a vaccine being approved before Christmas; Three coronavirus jabs are in late trial stages raising hopes of a vaccine being approved before Christmas. Matt Brooks Nov 19, 2020 822
Gannex Pharma Co and Sagimet Biosciences complete patient enrolment in the ASC40 phase two NASH trial in China. Nov 19, 2020 190
Gannex Pharma Co and Sagimet Biosciences complete patient enrolment in the ASC40 phase two NASH trial in China. Nov 19, 2020 186
What is it like to take part in a vaccine trial? Nov 19, 2020 867
What are clinical trials and how do they work? Nov 19, 2020 774
Duterte approves emergency use of COVID-19 vaccines; Pfizer vaccine 95% effective in final test. Geducos, Argyll Cyrus Nov 19, 2020 982
What are clinical trials and how do they work? Nov 19, 2020 778
Spain's medicine agency authorises Phase III trial of Johnson & Johnson COVID-19 vaccine. Nov 18, 2020 244
Spain's medicine agency authorises Phase III trial of Johnson & Johnson COVID-19 vaccine. Nov 18, 2020 248
Sanofi Says One Drug Gets US Fast Track And Another In Priority Review. Nov 18, 2020 248
Pfizer Reports 95% Success Rate in COVID-19 Vaccine Final Trial. Andrew G. Simpson Nov 18, 2020 935
Johnson & Johnson starts new UK COVID-19 vaccine trial with 6,000 participants. Nov 17, 2020 211
2nd vaccine 94.5% effective, trial shows. MARTIN BAGOT Nov 17, 2020 179
2nd vaccine 94.5% effective, trial shows. MARTIN BAGOT Nov 17, 2020 180
Johnson & Johnson starts new UK COVID-19 vaccine trial with 6,000 participants. Nov 17, 2020 209
Genome and Company's GEN-001 cleared for clinical trial. Nov 16, 2020 417
City to take part in vaccine trial. Nov 16, 2020 292
UK to lead final trials of vaccine. Nov 16, 2020 215
6000 Brits sought for jab trial. NINA MASSEY Nov 16, 2020 229
Janssen Pharmaceuticals starts new two-dose trials of its COVID-19 vaccine candidate in Britain. Nov 16, 2020 269
Janssen Pharmaceuticals starts new two-dose trials of its COVID-19 vaccine candidate in Britain. Nov 16, 2020 273
6,000 UK participants sought for final-stage Covid-19 vaccine trials. Nov 16, 2020 241
6,000 volunteers needed for final stage test of Covid vaccine; So far around 25,000 people in the UK have participated in vaccine trials. By, Neil Shaw Nov 16, 2020 636
Johnson & Johnson Seeks 6,000 UK Participants For Vaccine Trial. Nov 16, 2020 641
Medicago and GSK to begin final Covid-19 vaccine trials. Nov 13, 2020 333
Pfizer's fifth Phase 3 trial of abrocitinib meets primary and key secondary endpoints. Nov 12, 2020 207
Pfizer's fifth Phase 3 trial of abrocitinib meets primary and key secondary endpoints. Nov 12, 2020 211
CytoDyn raises $25M in convertible debt deal to fund its license applications and coronavirus trials. Nov 12, 2020 152
AstraZeneca posts positive late-stage trial results for asthma treatment. Nov 11, 2020 270
BREAKING Jonathan Van Tam explains how vaccine development has been sped up in coronavirus crisis; The Deputy CMO insists the new vaccine trials will be thorough regardless of the urgency -but warned that the roll out will take time. By, Oliver Milne Nov 11, 2020 665
Pfizer's Upjohn Closes Geodon Trial After Meets Primary Endpoint. Nov 11, 2020 156
Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen Cell Therapy for the Treatment of Dry Age-related Macular Degeneration. Clinical report Nov 11, 2020 595
Pfizer Touts Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens. Nov 11, 2020 224
Brazil halts trials of Chinese Covid-19 vaccine. Nov 10, 2020 574
AstraZeneca and Amgen report positive results from asthma trial. Nov 10, 2020 249
AstraZeneca and Amgen report positive results from asthma trial. Nov 10, 2020 248
AstraZeneca and Amgen report positive results from asthma trial. Nov 10, 2020 244
Bristol Myers Squibb Presents Late-Breaking Phase 2 Data Demonstrating the Safety and Efficacy of Deucravacitinib in Patients with Psoriatic Arthritis. Nov 9, 2020 1027
UPDATE: Pfizer Says Covid-19 Vaccine 90% Effective In Phase 3 Trial. Nov 9, 2020 257
China to begin clinical trials of AstraZeneca's COVID-19 vaccine. Nov 6, 2020 222
China to begin clinical trials of AstraZeneca's COVID-19 vaccine. Nov 6, 2020 226
Pfizer Touts Positive Phase 3 Study Results for Xeljanx (tofacitinib) in Ankylosing Spondylitis. Nov 6, 2020 212
AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. Nov 5, 2020 281
Small chance of vaccine by Christmas says head of Oxford/AstraZeneca trial. Nov 5, 2020 321
Chile and Peru permit AstraZeneca COVID-19 vaccine trials. Nov 5, 2020 283
Chile and Peru permit AstraZeneca COVID-19 vaccine trials. Nov 5, 2020 287
AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. Nov 5, 2020 277
NA Proactive news snapshot: Bioasis Technologies, OTC Markets Group, Phyto Therapeutics, NexTech AR Solutions UPDATE ... Nov 4, 2020 2766
Pfizer Initiates a Phase 2b Clinical Study of Vupanorsen. Clinical report Nov 4, 2020 506
Pfizer Inc starts Phase 2b vupanorsen (AKCEA-ANGPTL3-LRx) study. Nov 4, 2020 248
Pfizer Inc starts Phase 2b vupanorsen (AKCEA-ANGPTL3-LRx) study. Nov 4, 2020 244
First Patient Dosed with Camidanlumab Tesirine in Combination with Pembrolizumab in Ongoing Phase 1b Clinical Trial in Selected Solid Tumors. Nov 4, 2020 614
Head-to-Head Phase 3 Trial of Enhertu Versus T-DM1 Initiated in Patients with HER2 Positive Early Breast Cancer at High Risk After Neo-Adjuvant Therapy. Nov 3, 2020 355
Germany's CureVac announces its COVID-19 vaccine triggers immune response in Phase I trial. Nov 2, 2020 197
Germany's CureVac announces its COVID-19 vaccine triggers immune response in Phase I trial. Nov 2, 2020 201
Clinical trial goes on after US changes. Oct 31, 2020 169
Covid-19 trial begins as Kenya vaccinates its first volunteers. Oct 30, 2020 474
FDA studying Aussie pharma firm's bid for COVID-19 vaccine clinical trials. Oct 30, 2020 503
Shionogi's CEO says Japanese COVID-19 vaccine ready for December trial. Oct 29, 2020 260
Regeneron's COVID-19 antibody treatment shown to cut medical visits in a clinical trial. Oct 29, 2020 250
Shionogi's CEO says Japanese COVID-19 vaccine ready for December trial. Oct 29, 2020 256
Regeneron's COVID-19 antibody treatment shown to cut medical visits in a clinical trial. Oct 29, 2020 246
Dr. Reddy's Partners On Sputnik V vaccine Clinical Trials in India. Oct 29, 2020 350
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19. Oct 29, 2020 480
AstraZeneca reports high-level results from the PONENTE Phase 3b trial. Financial report Oct 29, 2020 157
Arcus Biosciences to collaborate with AstraZeneca on trial for domvanalimab. Oct 29, 2020 251
Cogstate expands global licensing deal with Japanese pharma Eisai. Oct 27, 2020 519
Early trial results of Oxford University and AstraZeneca's COVID-19 vaccine indicate it produces robust immune response in elderly. Oct 26, 2020 258
Early trial results of Oxford University and AstraZeneca's COVID-19 vaccine indicate it produces robust immune response in elderly. Oct 26, 2020 257
Early trial results of Oxford University and AstraZeneca's COVID-19 vaccine indicate it produces robust immune response in elderly. Oct 26, 2020 253
AstraZeneca announces positive results for Farxiga DAPA-CKD Phase III trial in patients with chronic kidney disease. Oct 26, 2020 268
AstraZeneca announces positive results for Farxiga DAPA-CKD Phase III trial in patients with chronic kidney disease. Oct 26, 2020 264
Novartis announces 'positive' Phase 2 interim analysis results for iptacopan. Oct 26, 2020 162
Regeneron and Sanofi's Dupixent shows additional Phase 3 positive results. Oct 26, 2020 274
What will COVID-19 vaccine trials tell us? Less than some may think. Oct 25, 2020 403
AstraZeneca, J&J vaccine trials back on track in US. Oct 24, 2020 523
IncellDx to Study CCR5 Antagonist Maraviroc in a COVID-19 Phase 2 Clinical Trial. Oct 22, 2020 204
Volunteer in Brazil trail of AstraZeneca COVID-19 vaccine trial dies; Trial to continue. Oct 22, 2020 244
Volunteer in Brazil trail of AstraZeneca COVID-19 vaccine trial dies; Trial to continue. Oct 22, 2020 248
AstraZeneca Covid-19 vaccine trial to continue after Brazilian volunteer dies. Oct 22, 2020 163
Sinovac Biotech seeks FDA approval on clinical trials for COVID-19 vaccine; Avigan trial to start soon. Oct 22, 2020 541
Volunteer dies during Oxford coronavirus vaccine trial; "Assessments have not led to any concerns about continuation of the ongoing study."". By, Neil Shaw Oct 22, 2020 553
Merck Touts Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine. Oct 22, 2020 906
AstraZeneca Covid-19 vaccine trial volunteer has died. Reuters News Service Oct 21, 2020 226
Pfizer and BioNTech commence combined trials of COVID-19 vaccine candidate in Japan. Oct 20, 2020 202
Pfizer and BioNTech commence combined trials of COVID-19 vaccine candidate in Japan. Oct 20, 2020 198
Merck reports 'positive' results from two additional Phase 3 studies of V114. Oct 20, 2020 210
Dr. Reddy's, RDIF Approved to Conduct Clinical Trial for Sputnik V Vaccine in India. Oct 20, 2020 306
Roche, AbbVie Land US Approval For Leukaemia Drug Venclexta. Oct 19, 2020 281
Phase 3 trial for GSK COVID drug. Oct 19, 2020 460
'Change of mind:' China-based pharma firm will not join vaccine trials. Oct 17, 2020 305
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 161
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 165
Eli Lilly pauses trial of its COVID-19 antibody drug over safety concern. Oct 14, 2020 325
Eli Lilly pauses trial of its COVID-19 antibody drug over safety concern. Oct 14, 2020 329
Eli Lilly supports DSMB decision to pause enrollment in ACTIV-3 clinical trial. Oct 14, 2020 257
Johnson & Johnson halts COVID-19 vaccine trials after unexplained illness. Oct 14, 2020 226
Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. Oct 14, 2020 505
Third vaccine trial paused because of safety concerns. Reuters News Service Oct 14, 2020 456
DOH awaits Johnson and Johnson docs, Covid vaccine trials halted. Oct 14, 2020 262
Johnson & Johnson halts COVID-19 vaccine trials after unexplained illness. Oct 14, 2020 228
Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. Oct 14, 2020 507
Seagen, Astellas Tout Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV in Advanced Urothelial Cancer. Oct 13, 2020 629
Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative Colitis. Oct 13, 2020 387
J and J halts covid-19 vaccine trial because of unexplained illness. Oct 13, 2020 496
J&J pauses COVID vaccine trials due to patient's 'unexplained illness'. Oct 13, 2020 223
J&J pauses COVID-19 vaccine trials due to unexplained illness in participant. Reuters News Service Oct 13, 2020 378
Johnson & Johnson temporarily pauses COVID-19 vaccine trials due to unexplained illness in a participant. Oct 13, 2020 325
Johnson & Johnson temporarily pauses COVID-19 vaccine trials due to unexplained illness in a participant. Oct 13, 2020 321
Coronavirus vaccine trial halted after participant suffers 'unexplained illness'; Johnson & Johnson said it had temporarily paused its coronavirus vaccine candidate clinical trials due to an unexplained illness in a study participant -refusing to elaborate further. By, Jeremy Culley Oct 13, 2020 497
Johnson & Johnson Pauses Covid Vaccine Trial As Participant Gets Sick. Oct 13, 2020 417
Gov't prepares for phase 3 of COVID-19 vaccine trials. Oct 12, 2020 428
AstraZeneca announces Phase III trials of COVID-19 antibodies and US funding. Oct 12, 2020 241
AstraZeneca announces Phase III trials of COVID-19 antibodies and US funding. Oct 12, 2020 245
AstraZeneca announces Phase III trials of COVID-19 antibodies and US funding. Oct 12, 2020 246
Bristol-Myers presents late-breaking data from Phase 3 True North trial. Oct 11, 2020 159
AstraZeneca's LAAB combo AZD7442 advances into Phase II clinical trials. Oct 9, 2020 241
Merck announces week 96 data from the Phase 2b trial (NCT03272347). Oct 8, 2020 166
Sputnik V, 2 other vaccine developers apply for possible conduct of trials here. Oct 8, 2020 359
3 int'l COVID-19 vaccine makers gunning for Phase 3 clinical trials in PH. Oct 8, 2020 354
PhaseBio Doses First Patients in Canada as Part of the REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of the Antiplatelet Effects of Ticagrelor. Oct 6, 2020 577
Novartis Notes Phase III Trial Showing Improved Beovu Treatment. Oct 5, 2020 221
MeiraGTx announces 9-month data from Phase 1/2 Trial of AAV-RPGR. Oct 4, 2020 319
Korean bio firms in race for COVID-19 treatment, vaccine development. Oct 3, 2020 417
AstraZeneca's COVID-19 vaccine trial resumes in Japan. Oct 2, 2020 256
AstraZeneca's COVID-19 vaccine trial resumes in Japan. Oct 2, 2020 260
AstraZeneca's COVID-19 vaccine trial resumes in Japan. Oct 2, 2020 261
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy. Oct 2, 2020 345
TOP NEWS: AstraZeneca Resumes Covid-19 Vaccine AZD1222 Trial In Japan. Oct 2, 2020 165
Eisai starts lorcaserin phase three clinical study. Clinical report Oct 1, 2020 220
Eisai starts lorcaserin phase three clinical study. Clinical report Oct 1, 2020 216
Novartis announces new interim data from ongoing Phase 3 STR1VE-EU trial. Oct 1, 2020 202
Care Access Research Partners with Lilly on Revolutionary Mobile Clinical Trial for COVID-19 Treatment. Oct 1, 2020 301
Novavax to start late-stage trials for COVID-19 vaccine in UK. Sep 26, 2020 262
Johnson & Johnson begins global Phase 3 registration trial for COVID-19 vaccine candidate. Clinical report Sep 25, 2020 221
Johnson & Johnson begins global Phase 3 registration trial for COVID-19 vaccine candidate. Clinical report Sep 25, 2020 217
AstraZeneca still waiting for US FDA decision to resume COVID-19 vaccine trials in US. Sep 24, 2020 178
AstraZeneca still waiting for US FDA decision to resume COVID-19 vaccine trials in US. Sep 24, 2020 182
TOP NEWS: Johnson & Johnson Starts Phase Three Covid-19 Vaccine Trial. Sep 23, 2020 253
Phase 3 Covid-19 vaccine trial begins in Pakistan. Sep 22, 2020 668
ALX Oncology, Merck to collaborate on Phase 2 immuno-oncology studies of ALX148. Sep 22, 2020 230
Phase 3 Covid-19 vaccine trial begins in Pakistan. Sep 22, 2020 1014
Phosplatin Therapeutics reveals data from Phase 1b dose escalation study of PT-112 used in combination with avelumab. Sep 21, 2020 274
Phosplatin Therapeutics reveals data from Phase 1b dose escalation study of PT-112 used in combination with avelumab. Sep 21, 2020 278
Seattle Genetics, Genmab Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020. Sep 21, 2020 584
OnKure, Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Combination of OKI-179 and Binimetinib. Sep 21, 2020 297
Merck announces data from Phase 3 KEYNOTE-590 trial of KEYTRUDA w/ chemotherapy. Sep 21, 2020 203
Vaccine makers will not be rushed. Sep 21, 2020 852
Clinical trials go on while the world waits for COVID vaccine. Sep 20, 2020 1162
AstraZeneca, Merck announce final results from Phase III PROfound trial. Sep 20, 2020 184
Moderna shares Covid-19 vaccine trial blueprints, Pfizer follows. Sep 18, 2020 763
Pfizer reports moderate side effects in COVID-19 vaccine trials. Sep 17, 2020 233
Interim Data Reported for COVID-19 Antibody in Phase 2 Clinical Trials. Clinical report Sep 17, 2020 528
BenevolentAI validates AI hypothesis for COVID-19 treatment under large randomised control trial. Sep 15, 2020 236
BenevolentAI validates AI hypothesis for COVID-19 treatment under large randomised control trial. Sep 15, 2020 240
Phase 3 Testing: Is The Vaccine Safe? Claudia Z Sep 15, 2020 600
AstraZeneca gets approval to resume trials of promising COVID-19 vaccine. Sep 14, 2020 152
AstraZeneca gets approval to resume trials of promising COVID-19 vaccine. Sep 14, 2020 156
Novartis Posts Positive Results From First Phase III Trial Of Beovu. Sep 14, 2020 180
AstraZeneca, Oxford University Resume Covid-19 Vaccine Trials In UK. Sep 14, 2020 267
VACCINE TRIALS TO RESUME. Sep 13, 2020 404
Vaccine trial resumes as virus continues grim march. Sep 13, 2020 677
AstraZeneca resumes trials of Covid vaccine halted by patient illness. Reuters News Service Sep 12, 2020 310
AstraZeneca given green light to resume Covid-19 vaccine trials. Michael Searles Sep 12, 2020 371
Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers. Sep 11, 2020 363
Record-breaking Covid-19 vaccine developed in less than a year. Sep 11, 2020 559
Takeda Releases Disappointing Results from Phase 3 Clinical Trial Evaluating Ninlaro in Newly Diagnosed Multiple Myeloma. Sep 11, 2020 514
Sanofi announces BIVV001 Phase 1/2a study results published in NEJM. Sep 10, 2020 154
Vertex Pharmaceuticals completes Phase 3 Trikafta study. Sep 10, 2020 260
TOP NEWS: Vaccine Still Possible Despite Trial Halt - AstraZeneca. Sep 10, 2020 419
Ill patient shows vac trials can't cut corners. JOE GAMMIE Sep 10, 2020 270
Pause in tests for new vaccines 'common' TRIALS. Sep 10, 2020 594
4,000 Kenyans to be recruited for Covid vaccine trials. Sep 9, 2020 379
Covid-19 vaccine trial paused after unexplained illness. Sep 9, 2020 645
TOP NEWS: Astra's Covid Vaccine Trial Paused After Unexplained Illness. Sep 9, 2020 766
Zion Pharma doses first patient in Phase 1 study of ZN-A-1041; Elects Wendy Li as CMO. Sep 8, 2020 224
Zion Pharma doses first patient in Phase 1 study of ZN-A-1041; Elects Wendy Li as CMO. Sep 8, 2020 228
Planning for the vaccine. Sep 8, 2020 682
DOH: Pfizer will not conduct clinical trials for COVID-19 vaccine in PH. Sep 7, 2020 311
Pharma chiefs vow no 'cut corners' in vaccine race. Sep 4, 2020 630
Sanofi and Glaxo commence Phase 1/2 trials of their COVID-19 vaccine. Sep 3, 2020 254
Sanofi and Glaxo commence Phase 1/2 trials of their COVID-19 vaccine. Sep 3, 2020 258
Florence Healthcare Supports Pfizer's COVID-19 Vaccine Clinical Trials with Extensive Connectivity Platform. Sep 3, 2020 263
Moment of truth for COVID-19 vaccines may be known this month. Sep 3, 2020 1172
Sanofi And Glaxo Aim For December Start For Phase 3 Of Vaccine Trial. Sep 3, 2020 188
'Service to humanity': Volunteers in Bahrain sign up for vaccine trial. Sep 2, 2020 566
Novartis reports published Phase 2 results of Tabrecta in NSLC. Financial report Sep 2, 2020 201
AstraZeneca commences Phase 3 trials of potential COVID-19 vaccine in the US. Sep 1, 2020 224
AstraZeneca commences Phase 3 trials of potential COVID-19 vaccine in the US. Sep 1, 2020 220
Boehringer Ingelheim, Eli Lilly Tout Full Results of Phase III Trial of Empagliflozin. Sep 1, 2020 518
FDA Clears Can-Fite to Start Phase II COVID-19 Study. Sep 1, 2020 486
AstraZeneca's COVID vaccine candidate AZD1222 enters into phase 3 trial. Aug 31, 2020 380
AstraZeneca says Farxiga demonstrated 'unprecedented' results in DAPA-CKD trial. Aug 30, 2020 246
TRITON Phase 3b study results presented at ESC 2020. Aug 30, 2020 316
Full results from EMPEROR-Reduced Phase III trial presented at ESC. Aug 30, 2020 535
Sputnik V, other potential COVID-19 vaccines have no FDA approval yet - DOH. Aug 27, 2020 635
AstraZeneca kicks off in-human trial for coronavirus treatment using monoclonal antibodies. Aug 26, 2020 422
AstraZeneca starts trial of antibody medication that prevents and treats Covid-19 infections; Drug has the potential to act as a preventative for people exposed to the virus as well as to treat patients already infected. By, Brett Gibbons Aug 25, 2020 336
Oxford COVID-19 vaccine trials could be complete in 2020. Aug 25, 2020 220
Oxford COVID-19 vaccine trials could be complete in 2020. Aug 25, 2020 216
Trump rails at FDA over vaccine development. McGinley, By Laurie; Johnson, Carolyn Y.; Post, Josh Dawsey The Washington Aug 23, 2020 1035
WHO urges nations to join global shared vaccine bid. Aug 19, 2020 584
TOP NEWS: Glaxo Vaccinates First Participant In Meningitis ABCWY Trial. Aug 19, 2020 293
Brazil approves human trials for potential J and J Covid-19 vaccine. Aug 18, 2020 210
The intricate path towards a COVID-19 vaccine. Editorial Aug 17, 2020 737
Andrew Lloyd Webber gets his Covid-19 vaccine trial shot to 'save the stage'. Aug 14, 2020 310
Pfizer Virus Vaccine Candidate Induces Immune Response, Trial Shows. Aug 12, 2020 584
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis. Aug 12, 2020 363
The race to develop a COVID vaccine. Aug 12, 2020 980
Mexico signs deals for coronavirus vaccine trials. Aug 12, 2020 197
Pre-orders of COVID-19 vaccine top five billion. Aug 12, 2020 620
Daiichi Sankyo Forges Clinical Trial Collaboration with AstraZeneca to Evaluate Patritumab Deruxtecan in Combination with TAGRISSO in EGFR-Mutated Non-Small Cell Lung Cancer. Aug 11, 2020 725
US conducts further clinical trial for remdesivir as COVID-19 treatment. Aug 7, 2020 525
Europe ramps up controls fearing second virus wave. Aug 6, 2020 846
Novavax Phase 1 data indicates its COVID-19 vaccine is safe and elicits an immune response. Aug 5, 2020 165
Novavax Phase 1 data indicates its COVID-19 vaccine is safe and elicits an immune response. Aug 5, 2020 169
NIH clinical trial of remdesivir plus interferon beta-1a for COVID-19 starts. Aug 5, 2020 280
Members of The COVID R and D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial. Aug 4, 2020 1064
Immunic reveals phase two multiple sclerosis trial positive top-line data. Aug 3, 2020 158
Immunic reveals phase two multiple sclerosis trial positive top-line data. Aug 3, 2020 154
Eli Lilly initiates Phase 3 trial of LY-CoV555 for prevention of COVID-19. Aug 3, 2020 300
GlaxoSmithKline, Sanofi to receive up to US$2.1bn from Washington to develop coronavirus vaccine. Aug 1, 2020 252
Fauci urges caution on China and Russia virus vaccines. Aug 1, 2020 524
Genmab announces Janssen's 'positive' results from Phase 3 APOLLO study. Jul 31, 2020 188
Two Covid-19 vaccines enter phase 3 of clinical trials. Jul 30, 2020 661
Arrowhead earns $20M milestone payment from Amgen for start of Phase 2 trial. Jul 29, 2020 246
AstraZeneca says chronic kidney disease drug passes final stage trial with flying colours. Jul 29, 2020 222
UK signs deal to secure 60 million doses of potential COVID-19 vaccine being developed by Sanofi and GSK. Jul 29, 2020 378
UK signs deal to secure 60 million doses of potential COVID-19 vaccine being developed by Sanofi and GSK. Jul 29, 2020 374
TOP NEWS: AstraZeneca Kidney Disease Drug Farxiga Successful In Trial. Jul 28, 2020 180
Pfizer, BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study. Clinical report Jul 28, 2020 890
Can-Fite Submits Investigational New Drug Application to US FDA for COVID-19 Phase II Study. Jul 28, 2020 352
Ending the pandemic will require innovation and access. Ubl, Steve Jul 27, 2020 944
Novavax Gets $1.6 Billion for Massive Vaccine Production. Jul 27, 2020 564
Biohaven Completes Enrollment Ahead of Timelines in International Phase 3 Clinical Trial of Verdiperstat in Multiple System Atrophy. Jul 23, 2020 693
Duterte's foreign policy tack will secure PH access to COVID-19 vaccine. Jul 23, 2020 525
Biohaven Completes Enrollment Ahead of Timelines in International Phase 3 Clinical Trial of Verdiperstat in Multiple System Atrophy. Jul 22, 2020 705
'No vaccine, no face-to-face classes,' Go maintains. Jul 22, 2020 750
AstraZeneca and Oxford University vaccine triggers immune response in trial. Jul 21, 2020 465
AstraZeneca's COVID-19 vaccine AZD1222 showed robust immune responses in all participants in phase I/II trial. Jul 21, 2020 407
AstraZeneca's COVID-19 vaccine AZD1222 showed robust immune responses in all participants in phase I/II trial. Jul 21, 2020 403
AIM Immunotech forms Phase 1/2a clinical trial agreement to fight the coronavirus. Jul 21, 2020 155
Oxford coronavirus vaccine safe and promising according to Phase 1 results published in the Lancet. Jul 21, 2020 1349
Coronavirus breakthrough as inhaled drug is shown to reduce risk of severe disease by 79%; Synairgen, the firm behind the drug, has published the results from its clinical trial of the drug, dubbed SNG001, in hospitalised Covid-19 patients. By, Shivali Best Jul 20, 2020 331
Oxford coronavirus vaccine trial shows promise (updated). Reuters News Service Jul 20, 2020 503
AstraZeneca announces results of Brilinta stroke drug's Phase III THALES trial. Jul 17, 2020 246
AstraZeneca announces results of Brilinta stroke drug's Phase III THALES trial. Jul 17, 2020 250
UK, US and Canada accuse Russia of vaccine research hacking. Jul 17, 2020 765
ADC Therapeutics says first patient dosed in pivotal Phase 2 portion of LOTIS 3. Jul 17, 2020 172
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. Jul 16, 2020 504
Vaccine hopes get trial boost. Jul 16, 2020 161
Merck announces clinical trial collaboration agreement with Oncorus for ONCR-177. Jul 16, 2020 210
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. Jul 16, 2020 502
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance. Jul 15, 2020 554
Novocure, Merck enter clinical trial collaboration to develop NSCLC treatment. Jul 15, 2020 153
Pfizer, BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2. Jul 13, 2020 431
OP-ED: Is Bangladesh capable of developing a new vaccine? Jul 13, 2020 1832
Company Completes Dosing In Phase 3 ALS Trial. Jul 13, 2020 357
Enanta Pharmaceuticals Touts Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus. Jul 10, 2020 645
PTC Therapeutics doses first patient in phase one clinical trial of PTC857. Jul 9, 2020 170
PTC Therapeutics doses first patient in phase one clinical trial of PTC857. Jul 9, 2020 174
Ideaya doses first patient in Phase 1 combination study of IDE196/binimetinib. Jul 9, 2020 161
Ridgeback Biotherapeutics Starts Enrollment for Phase 2 Trial of Potential COVID-19 Treatment. Jul 8, 2020 402
Brazil to become testing ground for coronavirus vaccine. Jul 8, 2020 732
US Food and Drug Administration Has Lifted Partial Clinical Hold on Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine. Jul 7, 2020 568
Regeneron announces start of REGN-COV2 Phase 3 COVID-19 prevention trial. Jul 6, 2020 232
Regeneron Starts REGN-COV2 Phase 3 COVID-19 Prevention Trial in Collaboration with National Institute of Allergy and Infectious Diseases. Jul 6, 2020 450
Pfizer and BioNTech shares jump as early data from coronavirus vaccine trial cheers investors. Jul 2, 2020 383
Pfizer and BioNTech shares jump as early data from coronavirus vaccine trial cheers investors. Jul 2, 2020 381
Pfizer, BioNTech announce early data from Phase 1/2 study of vaccine candidate. Jul 1, 2020 791
Kiniksa says Phase 3 trial of rilonacept meets efficacy endpoints. Jun 29, 2020 535
Lineage Re-Starts Enrollment In Clinical Study Of Treatment For Dry AMD. Jun 29, 2020 845
First Patient Dosed in Phase 1b/2a Study of NT-I7 (efineptakin alfa) and KEYTRUDA (pembrolizumab) in Patients with Relapsed/Refractory Advanced Solid Tumors. Jun 25, 2020 345
RxE2 and Thrifty White Pharmacy Establish First E2 Dispensing Service for Clinical Drug Trials in the US. Jun 25, 2020 409
Stirling company to make virus vaccine; Symbiosis will supply trials. ALASTAIR MCNEILL Jun 24, 2020 420
Trials with Oxford Covid-19 vaccine start in Brazil. Jun 23, 2020 177
Pfizer Starts Four Phase 3 Clinical Trials for Investigational Vaccines. Jun 23, 2020 673
Pfizer announces initiation of four Phase 3 investigational vaccine studies. Jun 22, 2020 153
Eli Lilly begins Phase 3 trial with baricitinib in COVID-19 patients. Jun 18, 2020 446
Novo Nordisk says Phase 2 AM833 trial reached primary endpoint. Jun 18, 2020 244
Recordati Announces Positive Results From Isturisa Phase Three Trial. Clinical report Jun 17, 2020 218

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters